Tessenderlo Group NV (TESB) | Financial Analysis & Statements
Tessenderlo Group NV Large-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2013Income Metrics
Revenue
346.1M
Gross Profit
61.2M
17.68%
Operating Income
3.1M
0.90%
Net Income
-17.8M
-5.14%
Balance Sheet Metrics
Total Assets
2.6B
Total Liabilities
938.2M
Shareholders Equity
1.7B
Debt to Equity
0.55
Cash Flow Metrics
Operating Cash Flow
15.3M
Free Cash Flow
-12.9M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2013
Annual Income Flow
2025
Tessenderlo Group NV Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.8B | 2.6B | 2.9B | 2.6B | 2.1B |
| Cost of Goods Sold | 2.2B | 2.1B | 2.4B | 1.9B | 1.5B |
| Gross Profit | 525.7M | 513.1M | 558.2M | 668.0M | 547.0M |
| Gross Margin % | 19.0% | 19.4% | 19.1% | 25.8% | 26.3% |
| Operating Expenses | |||||
| Research & Development | 27.3M | 28.8M | 29.5M | 13.1M | 10.4M |
| Selling, General & Administrative | 421.0M | 419.6M | 406.2M | 349.1M | 306.6M |
| Other Operating Expenses | 16.4M | 10.1M | 4.5M | -8.1M | 1.4M |
| Total Operating Expenses | 464.7M | 458.5M | 440.2M | 354.1M | 318.4M |
| Operating Income | 66.2M | 58.7M | 119.5M | 313.7M | 227.3M |
| Operating Margin % | 2.4% | 2.2% | 4.1% | 12.1% | 10.9% |
| Non-Operating Items | |||||
| Interest Income | 6.8M | 10.4M | 9.8M | 900.0K | 400.0K |
| Interest Expense | 11.4M | 10.3M | 10.1M | 8.5M | 9.7M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -57.3M | 46.6M | 116.4M | 289.2M | 230.9M |
| Income Tax | 22.9M | 2.6M | 2.0M | 62.4M | 42.6M |
| Effective Tax Rate % | 0.0% | 5.6% | 1.7% | 21.6% | 18.4% |
| Net Income | -80.2M | 44.0M | 114.4M | 226.8M | 188.3M |
| Net Margin % | -2.9% | 1.7% | 3.9% | 8.8% | 9.0% |
| Key Metrics | |||||
| EBITDA | 230.5M | 296.8M | 313.1M | 514.4M | 373.2M |
| EPS (Basic) | €-1.34 | €0.70 | €1.74 | €5.26 | €4.36 |
| EPS (Diluted) | €-1.34 | €0.70 | €1.74 | €5.26 | €4.36 |
| Basic Shares Outstanding | 60613705 | 61467934 | 63057142 | 43094553 | 43022979 |
| Diluted Shares Outstanding | 60613705 | 61467934 | 63057142 | 43094553 | 43022979 |
Income Statement Trend
Tessenderlo Group NV Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 158.0M | 182.4M | 177.0M | 156.1M | 320.3M |
| Short-term Investments | - | 70.0M | - | - | 10.0M |
| Accounts Receivable | 366.7M | 372.2M | 388.7M | 373.4M | 332.4M |
| Inventory | 530.9M | 560.3M | 604.5M | 567.0M | 393.4M |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 1.1B | 1.3B | 1.3B | 1.2B | 1.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 762.3M | 704.5M | 670.9M | 570.9M | 536.8M |
| Goodwill | 245.5M | 393.8M | 350.5M | 171.2M | 173.8M |
| Intangible Assets | 176.1M | 244.2M | 286.9M | 107.0M | 109.2M |
| Long-term Investments | 0 | 1.1M | 300.0K | 0 | - |
| Other Non-Current Assets | -100.0K | -100.0K | - | -100.0K | -100.0K |
| Total Non-Current Assets | 1.5B | 1.7B | 1.7B | 1.1B | 1.1B |
| Total Assets | 2.6B | 2.9B | 2.9B | 2.3B | 2.2B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 281.3M | 279.5M | 260.3M | 272.8M | 247.9M |
| Short-term Debt | 92.1M | 123.3M | 61.6M | 56.2M | 211.5M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 550.7M | 599.7M | 490.2M | 453.5M | 597.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 107.2M | 134.1M | 175.3M | 209.3M | 193.6M |
| Deferred Tax Liabilities | 96.3M | 114.1M | 126.5M | 56.3M | 65.4M |
| Other Non-Current Liabilities | -100.0K | - | -400.0K | 100.0K | -100.0K |
| Total Non-Current Liabilities | 387.5M | 422.7M | 475.7M | 444.1M | 477.8M |
| Total Liabilities | 938.2M | 1.0B | 965.9M | 897.6M | 1.1B |
| Equity | |||||
| Common Stock | 428.3M | 428.3M | 428.3M | 216.2M | 216.2M |
| Retained Earnings | - | - | - | - | - |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.7B | 1.9B | 1.9B | 1.4B | 1.1B |
| Key Metrics | |||||
| Total Debt | 199.3M | 257.4M | 236.9M | 265.5M | 405.1M |
| Working Capital | 598.5M | 667.8M | 767.5M | 699.9M | 503.7M |
Balance Sheet Composition
Tessenderlo Group NV Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -80.2M | 44.0M | 114.4M | 226.8M | 188.3M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 5.1M | 83.8M | 84.6M | -196.9M | -145.2M |
| Operating Cash Flow | -74.0M | 126.1M | 205.5M | 29.9M | 40.9M |
| Investing Activities | |||||
| Capital Expenditures | -130.1M | -178.5M | -176.9M | -111.2M | -88.7M |
| Acquisitions | -900.0K | -60.7M | 40.2M | -42.1M | 0 |
| Investment Purchases | - | 0 | -70.0M | -50.0M | -40.0M |
| Investment Sales | 70.0M | 7.2M | 130.7M | 10.0M | 50.0M |
| Investing Cash Flow | -60.9M | -232.0M | -76.1M | -193.4M | -78.7M |
| Financing Activities | |||||
| Share Repurchases | -37.0M | -47.3M | -32.4M | -600.0K | 0 |
| Dividends Paid | -45.0M | -54.0M | -39.9M | - | - |
| Debt Issuance | 112.0M | 65.0M | 5.8M | 60.0M | 1.3M |
| Debt Repayment | -181.2M | -39.8M | -43.7M | -198.0M | -48.7M |
| Financing Cash Flow | -136.5M | -61.8M | -88.4M | -135.6M | -42.8M |
| Free Cash Flow | 74.3M | 152.6M | 40.7M | 86.4M | 152.1M |
| Net Change in Cash | -271.4M | -167.7M | 41.0M | -299.1M | -80.6M |
Cash Flow Trend
Tessenderlo Group NV Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
37.21
Forward P/E
10.63
Price to Book
0.74
Price to Sales
0.46
PEG Ratio
10.63
Profitability Ratios
Profit Margin
-2.94%
Operating Margin
0.85%
Return on Equity
-4.43%
Return on Assets
1.39%
Financial Health
Current Ratio
2.09
Debt to Equity
11.70
Beta
0.57
Per Share Data
EPS (TTM)
€-1.34
Book Value per Share
€28.65
Revenue per Share
€45.59
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| TESB | 1.3B | 37.21 | 0.74 | -4.43% | -2.94% | 11.70 |
| Biotalys N.V | 87.5M | -5.82 | 4.40 | -75.33% | 0.00% | 21.67 |
| Syneos Health | 5.7B | 377.86 | 0.94 | -1.25% | -1.04% | 48.61 |
| Titan Cement | 3.5B | 14.74 | 1.77 | 13.18% | 8.85% | 33.45 |
| Solvay SA | 2.9B | 99.64 | 2.86 | 2.98% | 0.63% | 200.56 |
| Azelis Group NV | 2.5B | 22.61 | 0.94 | 4.03% | 2.71% | 69.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.